Timothy G. Whitsett, Ph.D. - Publications
Affiliations: | 2007 | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Toxicology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Whitsett TG, Loftus JC, Winkles JA, Tran NL. New insights into the functional consequences of ephrin A3 mutations in non-small cell lung cancer. Translational Lung Cancer Research. 2: 3-5. PMID 25806199 DOI: 10.3978/J.Issn.2218-6751.2012.10.05 | 0.345 | |||
2013 | Kim TY, Jackson S, Xiong Y, Whitsett TG, Lobello JR, Weiss GJ, Tran NL, Bang YJ, Der CJ. CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth. Proceedings of the National Academy of Sciences of the United States of America. 110: 16868-73. PMID 24082123 DOI: 10.1073/Pnas.1306358110 | 0.327 | |||
2006 | Whitsett TG, Lamartiniere CA. Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert Review of Anticancer Therapy. 6: 1699-706. PMID 17181483 DOI: 10.1586/14737140.6.12.1699 | 0.445 | |||
2006 | Whitsett T, Carpenter M, Lamartiniere CA. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. Journal of Carcinogenesis. 5: 15. PMID 16700914 DOI: 10.1186/1477-3163-5-15 | 0.443 | |||
Show low-probability matches. |